Literature DB >> 12204371

Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite.

Marie-Pierre Brenier-Pinchart1, Inés Vigan, Evelyne Jouvin-Marche, Patrice Noél Marche, Elisabeth Pelet, Uwe Gross, Pierre Ambroise-Thomas, Hervé Pelloux.   

Abstract

Infection of human fibroblasts with tachyzoites of RH and Prugniaud strains, two different strains of Toxoplasma gondii, significantly increased monocyte chemotactic protein (MCP)-1 secretion contrary to what happened with bradyzoites of the cystogenetic strain. Quantification of MCP-1 mRNA by RT-PCR showed that this phenomenon is regulated at the transcriptional level. Thus, the stage of parasite can be deciding in MCP-1 induction since only tachyzoites induced MCP-1 expression and secretion. MCP-1 induced by tachyzoites could be involved in cell recruitment, as shown by the quantification of MCP1 ARNm by real-time PCR (LightCycler, Roche Diagnostics), in the pathogenesis of T. gondii infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204371     DOI: 10.1111/j.1574-6968.2002.tb11323.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

Review 1.  Monocyte-mediated defense against microbial pathogens.

Authors:  Natalya V Serbina; Ting Jia; Tobias M Hohl; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

2.  Interferon gamma effect on immune mediator production in human nerve cells infected by two strains of Toxoplasma gondii.

Authors:  Nour Mammari; Philippe Vignoles; Mohamad Adnan Halabi; Marie-Laure Dardé; Bertrand Courtioux
Journal:  Parasite       Date:  2015-12-21       Impact factor: 3.000

3.  In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication.

Authors:  Nour Mammari; Philippe Vignoles; Mohamad Adnan Halabi; Marie Laure Darde; Bertrand Courtioux
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.